Cite
HARVARD Citation
Freeman, R. et al. (2022). Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages. Annals of clinical and translational neurology. 9 (9), pp. 1370-1383. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Freeman, R. et al. (2022). Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages. Annals of clinical and translational neurology. 9 (9), pp. 1370-1383. [Online].